Full Text
Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain

Abstract

Authors

JM Carrascosa F Vanaclocha T Caloto M Echave I Oyagüez T Tencer

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×